Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGINTERVENTIONAL

Study of Self-Recognition and Self/Other Distinction Disorders in Patients With Psychological Vulnerability

Study of Self-Recognition and Self/Other Distinction Disorders in Patients With Psychological Vulnerability (ALTER EGO)

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

The main objective of this study is to establish whether there are differences in self-recognition and self/other distinction in subjects with psychological vulnerability compared to healthy volunteer controls.

Who May Be Eligible (Plain English)

Inclusion criteria for patients: - Aged from 15 to 25 years - Subject meeting the Ultra High Risk criteria at CAARMS and / or SPI-A - Signature of the consent (participants and parents for minors) - Subject affiliated to the social security scheme or benefiting from such a scheme Inclusion criteria for healthy volunteers: - Aged from 15 to 25 years - Subject not familiar to the patient to whom it is matched - Signature of the consent (participants and parents for minors) - Subject affiliated to the social security scheme or benefiting from such a scheme Exclusion Criteria for both patients and healthy volunteers: - History of epilepsy and / or migraine (due to the epileptogenic potential of light stimuli) - Refusal of participation of the minor even if the legal representatives want the subject to participate in the study - Claustrophobia - Wearing glasses - Abnormal right and left visual acuity without contact lenses - Distinctive signs on the face which cannot be temporarily removed - Subject under legal protection (curators / guardianship) or deprived of liberty Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion criteria for patients: * Aged from 15 to 25 years * Subject meeting the Ultra High Risk criteria at CAARMS and / or SPI-A * Signature of the consent (participants and parents for minors) * Subject affiliated to the social security scheme or benefiting from such a scheme Inclusion criteria for healthy volunteers: * Aged from 15 to 25 years * Subject not familiar to the patient to whom it is matched * Signature of the consent (participants and parents for minors) * Subject affiliated to the social security scheme or benefiting from such a scheme Exclusion Criteria for both patients and healthy volunteers: * History of epilepsy and / or migraine (due to the epileptogenic potential of light stimuli) * Refusal of participation of the minor even if the legal representatives want the subject to participate in the study * Claustrophobia * Wearing glasses * Abnormal right and left visual acuity without contact lenses * Distinctive signs on the face which cannot be temporarily removed * Subject under legal protection (curators / guardianship) or deprived of liberty

Treatments Being Tested

OTHER

Double mirror device ALTER-EGO

The patient and his matched healthy volunteer will be placed on each side of the double mirror device ALTER-EGO. Both sides will be lightened alternatively or at the same time by lights, so according to the light intensity, the subject will see himself in a mirror or the other person throw a classic window. The light intensity will vary from 0 to 100% and to 100% to 0% alternatively from each side of the mirror. At each 10% variation of one side, both patient and volunteer will have to answer that question : "who do you see more : him/her or yourself ?"

OTHER

EASE test

The patient will have to answer the EASE test which is a specific test to detect patient with high risk of psychosis or schizophrenia

Locations (1)

CHRU BREST Hôpital de Bohars
Bohars, France